30 related articles for article (PubMed ID: 31477374)
1. Cortisol response in individuals with genetic risk of schizophrenia. Some considerations.
José BJ; Antonio GA; Reveca GF
Schizophr Res; 2024 Jul; 269():56-57. PubMed ID: 38733799
[No Abstract] [Full Text] [Related]
2. Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia.
Martel JC; Gatti McArthur S
Front Pharmacol; 2020; 11():1003. PubMed ID: 32765257
[TBL] [Abstract][Full Text] [Related]
3. Genetic risks of schizophrenia identified in a matched case-control study.
Oishi K; Niitsu T; Kanahara N; Sato Y; Iwayama Y; Toyota T; Hashimoto T; Sasaki T; Takase M; Shiina A; Yoshikawa T; Iyo M
Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):775-781. PubMed ID: 32623490
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic pathway gene polymorphisms and genetic susceptibility to schizophrenia among north Indians.
Srivastava V; Deshpande SN; Thelma BK
Neuropsychobiology; 2010; 61(2):64-70. PubMed ID: 20016224
[TBL] [Abstract][Full Text] [Related]
5. Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia.
Oishi K; Kanahara N; Takase M; Oda Y; Nakata Y; Niitsu T; Ishikawa M; Sato Y; Iyo M
PLoS One; 2018; 13(11):e0207133. PubMed ID: 30408108
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase gene expression in stress-induced and non-stress induced schizophrenia.
Aghamaleki-Sarvestani Z; Vousooghi N; Tabrizi M; Alipour ME; Alaghband-Rad J; Mostafavi-Abdolmaleky H; Zarindast MR
Psychiatr Genet; 2020 Feb; 30(1):10-18. PubMed ID: 31568068
[TBL] [Abstract][Full Text] [Related]
7. Early-onset schizophrenia and dopamine-related gene polymorphism.
Iwata Y; Matsumoto H; Minabe Y; Osada N; Nakamura K; Sekizawa T; Suzuki K; Sekine Y; Takei N; Mori N
Am J Med Genet B Neuropsychiatr Genet; 2003 Jan; 116B(1):23-6. PubMed ID: 12497608
[TBL] [Abstract][Full Text] [Related]
8. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
[TBL] [Abstract][Full Text] [Related]
9. Genetic combination risk for schizophrenia.
Oishi K; Niitsu T; Kanahara N; Hashimoto T; Komatsu H; Sasaki T; Takase M; Sato Y; Iyo M
Schizophr Res; 2020 Jan; 215():473-474. PubMed ID: 31477374
[No Abstract] [Full Text] [Related]
10. [Genetic polymorphism of COMT in mental disorders].
Tylec A; Stryjecka-Zimmer M; Kucharska-Pietura K
Psychiatr Pol; 2007; 41(4):473-83. PubMed ID: 18046978
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of schizophrenia: past, present and future.
Prasad S; Semwal P; Deshpande S; Bhatia T; Nimgaonkar VL; Thelma BK
J Biosci; 2002 Feb; 27(1 Suppl 1):35-52. PubMed ID: 11927776
[TBL] [Abstract][Full Text] [Related]
12. [The role of genetic variants of the dopaminergic system in heroin dependence].
Vereczkei A; Sasvári-Székely M; Barta C
Neuropsychopharmacol Hung; 2009 Jun; 11(2):95-101. PubMed ID: 19827317
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
